Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Apple Inc. -- Ignore unavailable to you. Want to Upgrade?

To: spyder66 who wrote (211029)	10/29/2021 1:07:30 PM
From: Art Bechhoefer	Read Replies (3) \| Respond to of 213037

Maybe the analysts aren't even writing anything but are relying on computer algorithms. Apple had a pretty decent earnings report. So did several other companies. Even when earnings guidance was positive, the share prices of the companies dropped. Apple is no exception. Another company I follow is Gilead Sciences, which reported earnings gains of about 18% yesterday. Also pretty decent guidance. GILD shares are down about 3% today. Computerized trading, based on algorithms that often are proprietary, are used frequently for exchange traded funds, where all stocks in a particular category may be affected. Among tech stocks, Apple and many of its suppliers have been affected downward on the assumption that supply shortages will continue. Among biotech stocks, especially smaller, development stage firms, similar downward pressure is exerted, especially because many, if not most of these smaller stocks pay no dividend and may earn little or no money at this stage. Gilead, like Apple is an exception. Both companies reported really decent earnings, but both stocks fell after hours and in trading today. Meanwhile you have stocks like Tesla, valued more than Ford and GM combined. It makes no sense. I'd suggest looking for stocks with low downside risk, and I include Apple in this category because of its large cash reserves, dividends, cash buybacks, popular brand name, and future earnings, even if dampened by supply shortages. Art